文献速递功能神经外科脑血管病外科

内镜与显微镜微血管减压术治疗颅神经综合征的Meta分析

A Meta-Analysis of Endoscopic Microvascular Decompression versus Microscopic Microvascular Decompression for the Treatment for Cranial Nerve Syndrome Caused by Vascular Compression.
PubMed 文献 · World Neurosurg · 2019-02-15

该Meta分析纳入9项研究共1093例患者(内镜组543例,显微镜组550例),比较内镜与显微镜微血管减压术治疗原发性三叉神经痛、面肌痉挛及舌咽神经痛的疗效与安全性。内镜组近期缓解率、责任血管发现率及远期缓解率均显著高于显微镜组,围手术期并发症显著低于显微镜组。

要点

  • 内镜组近期缓解率92% vs 显微镜组86%(OR 1.71,P=0.0089),内镜组更高
  • 内镜组责任血管发现率99% vs 95%(OR 2.76,P=0.0061),内镜组更高
  • 内镜组远期缓解率97% vs 87%(OR 4.59,P=0.0036),内镜组更高;围手术期并发症23% vs 35%(OR 0.56,P<0.0001),内镜组更低

核心结论

  • 该Meta分析证实内镜微血管减压术在围手术期和术后(短期和长期)疗效上均优于显微镜微血管减压术,因此作者认为应将其视为神经痛和面肌痉挛患者的合适治疗选择。

研究设计与样本

  • 系统检索PubMed、Embase、Web of Science、Cochrane Central Register of Controlled Trials、中国生物医学文献数据库及中国知网,检索时间范围为1966年1月至2018年3月,不限制文献语言。
  • 共纳入9项研究、1093例患者(内镜微血管减压术543例 vs 显微镜微血管减压术550例),比较围手术期安全性与术后疗效,并进行了单臂和累积Meta分析。
  • 所有结局以比值比(OR)及95%置信区间表示,使用R语言计算。

主要发现

  • 近期缓解率内镜组92% vs 显微镜组86%(OR 1.71,P=0.0089),内镜组显著更高。
  • 责任血管发现率内镜组99% vs 显微镜组95%(OR 2.76,P=0.0061),内镜组显著更高。
  • 远期缓解率内镜组97% vs 显微镜组87%(OR 4.59,P=0.0036),内镜组显著更高。
  • 围手术期并发症内镜组23% vs 显微镜组35%(OR 0.56,P<0.0001),内镜组显著更低。

关键数值与推荐

  • 近期缓解率:内镜组92% vs 显微镜组86%,OR 1.71,P=0.0089。
  • 责任血管发现率:内镜组99% vs 显微镜组95%,OR 2.76,P=0.0061。
  • 远期缓解率:内镜组97% vs 显微镜组87%,OR 4.59,P=0.0036。
  • 围手术期并发症:内镜组23% vs 显微镜组35%,OR 0.56,P<0.0001。

临床怎么用

  • 作者认为内镜微血管减压术在围手术期及术后短期、长期疗效上均优于显微镜微血管减压术,应将其视为神经痛和面肌痉挛患者的合适治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare the efficacy and safety of endoscopic microvascular decompression (E-MVD) and microscopic microvascular decompression (M-MVD) for the treatment for cranial nerve syndrome caused by vascular compression, including primary trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia. METHODS: A systematic search of the online databases, including PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials, China Biology Medicine disc, and China National Knowledge Infrastructure, was performed from January 1966 to March 2018. The language of the included literature was not limited. Relevant outcomes of perioperative safety and postoperative efficacy were considered for meta-analysis. Single-arm and cumulative meta-analyses were also conducted. All the outcomes were calculated as odds ratios (ORs) with 95% confidence intervals using R language. RESULTS: A total of 9 studies involving 1093 (E-MVD [543] vs. M-MVD [550]) patients were included for analysis in our study. The recent remission rate (92% vs. 86%; OR, 1.71; P = 0.0089), offending vessel discovery rate (99% vs. 95%; OR 2.76, P = 0.0061), and long-term remission rate (97% vs. 87%; OR 4.59, P = 0.0036) were significantly higher in patients who underwent E-MVD than in those who underwent M-MVD, whereas perioperative complications (23% vs. 35%; OR 0.56, P < 0.0001) were significantly lower in patients who underwent E-MVD. CONCLUSIONS: This meta-analysis confirms that E-MVD is superior to M-MVD both in perioperative and postoperative efficacy (short- and long-term), and therefore it should be considered as an appropriate treatment choice for patients with neuralgia and hemifacial spasm.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Li Y, Mao F, Cheng F, et al. A Meta-Analysis of Endoscopic Microvascular Decompression versus Microscopic Microvascular Decompression for the Treatment for Cranial Nerve Syndrome Caused by Vascular Compression. World Neurosurg. 2019. PMID: 30776512. doi:10.1016/j.wneu.2019.01.220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。